Drug News
-
Bipolar Patients May Benefit From Long-Term Use Of Antidepressants – Study
The results of a new trial suggest that modern antidepressants might be effective for long-term treatment of some patients with…
Read More » -
How To Insert A Menstrual Disc
A menstrual disc is a flexible, circular device designed to collect menstrual fluid internally, offering an alternative to traditional sanitary…
Read More » -
Why CDC Recommended AstraZeneca and Sanofi’s Infant RSV Immunization
In a significant development, a unanimous recommendation has been put forth by a CDC advisory committee in support of the…
Read More » -
Dr. Leigh Briscoe-Dwyer Emerge As New President Of ASHP
Dr. Leigh Briscoe-Dwyer, a distinguished pharmacist, has taken on a prominent leadership role in the healthcare community as the president…
Read More » -
Pfizer Responds to Tornado Impact Place 12 Key Solutions On Emergency Order
In the wake of a devastating tornado that struck Pfizer’s facility in Rocky Mount, N.C., the company has introduced a…
Read More » -
Opioid Medications Reach Just 20% of U.S. Opioid Strugglers – Study
The persistent and troubling U.S. opioid abuse epidemic remains a critical issue, as overdose deaths continue to soar. Despite the…
Read More » -
Controversial Dupixent Commercial Driving Sales OF New Eczema Drug
https://youtu.be/OIS0pOYK8GE Jolie, the youthful dancer showcased in the Dupixent commercial, achieved recognition following her appearance. However, despite the ensuing controversy…
Read More » -
FDA Approves Sage Therapeutics Zurzuvae For Postpartum Depression (PPD)
On August 04, 2023, the U.S. Food and Drug Administration (FDA) reached a groundbreaking decision by granting its approval for…
Read More » -
Galapagos Withdraws Jyseleca Applications in Europe and Revises Sales Projections
Galapagos, a Belgium biotech company, has experienced setbacks with its drug Jyseleca (filgotinib). Based on the results of a phase…
Read More » -
ReVive: The Second OTC Naloxone Spray Approved by FDA
The U.S. Food and Drug Administration (FDA) has taken a significant step forward in addressing the opioid crisis by approving…
Read More »